LIOPF(LIOPF)
LIOPF
No analyst ratings available
No analyst price targets available for LIOPF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $443.41B | $448.86B | $460.50B | $473.35B | $483.68B |
| Low | $431.89B | $435.02B | $447.41B | $459.90B | $469.93B |
| High | $462.87B | $463.78B | $478.25B | $491.59B | $502.32B |
| EBITDA Avg | $61.39B | $64.88B | $69.84B | $72.78B | $76.57B |
| Low | $59.99B | $63.41B | $68.23B | $71.11B | $74.79B |
| High | $63.28B | $66.88B | $72.02B | $75.06B | $78.98B |
| EBIT Avg | $38.67B | $40.82B | $44.56B | $46.36B | $49.10B |
| Low | $37.27B | $39.35B | $42.95B | $44.69B | $47.32B |
| High | $40.55B | $42.82B | $46.75B | $48.64B | $51.51B |
| Net Income Avg | $25.70B | $27.18B | $29.72B | $30.95B | $32.82B |
| Low | $24.75B | $26.17B | $28.63B | $29.81B | $31.60B |
| High | $26.99B | $28.54B | $31.21B | $32.50B | $34.46B |
| EPS Avg | $92.84 | $98.15 | $107.36 | $111.79 | $118.53 |
| Low | $89.41 | $94.53 | $103.40 | $107.66 | $114.15 |
| High | $97.49 | $103.07 | $112.74 | $117.39 | $124.47 |
| Analysts (Rev / EPS) | 12 / 1 | 12 / 1 | 5 / 1 | 10 / 1 | 6 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $109.00B | $118.57B |
| Low | $106.43B | $113.70B |
| High | $114.24B | $124.73B |
| EBITDA Avg | $19.21B | $18.87B |
| Low | $18.65B | $18.33B |
| High | $20.06B | $19.70B |
| EBIT Avg | $13.32B | $12.89B |
| Low | $12.77B | $12.35B |
| High | $14.18B | $13.72B |
| Net Income Avg | $8.95B | $8.66B |
| Low | $8.57B | $8.29B |
| High | $9.53B | $9.22B |
| EPS Avg | $32.32 | $31.26 |
| Low | $30.94 | $29.93 |
| High | $34.42 | $33.30 |
| Analysts (Rev / EPS) | 8 / 1 | 8 / 1 |